News
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
Digestion issues, fatigue, and high costs haven’t stopped some from finding power and transformation through GLP-1 ...
What Happened: file made a significant move by purchasing 1,565 shares of Eli Lilly as reported in a Form 4 filing with the U.S. Securities and Exchange Commission. The transaction's total worth ...
Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.
In a recent SEC filing, it was revealed that David A Ricks, President at Eli Lilly LLY, made a noteworthy insider purchase on August 12,. What Happened: Ricks demonstrated confidence in Eli Lilly by ...
The Trump administration is directing the Department of Health and Human Services to identify about 26 “critical medicines.” ...
6d
Soy Nómada on MSNMedicare and Medicaid Could Start Covering Anti-Obesity Drugs
A groundbreaking initiative from the Trump administration could revolutionize access to costly weight-loss drugs under Medicare and Medicaid. This plan aims to provide millions of Americans suffering ...
2don MSN
Mounjaro Is About to Get More Expensive in the UK: Here Are Cheaper Alternatives Available Right Now
Mounjaro's UK price will rise by 170% in September, prompting interest in cheaper alternatives like semaglutide for weight loss.
Rising health-care costs also are once again outpacing overall inflation, according to a Mercer survey of businesses, with ...
5d
Inquirer on MSNBattle of the bulge: Will China’s home-grown obesity drugs reshape global weight loss market?
Chinese drugmakers are racing to roll out cheaper or more innovative alternatives. Read more at straitstimes.com. Read more ...
How do we make Chili’s relevant again?” he asked. “How do we remind people why they loved this brand in the first place?” In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results